@article{672f0014a6f34e5988e99a9ecd6bb5c2,
title = "Is reimbursement for alerts and real-time continuous glucose monitoring needed?",
author = "Kirsten N{\o}rgaard and Signe Schmidt",
note = "Funding Information: KN serves as adviser for Abbott Diabetes Care, Denmark on future product ideas and for Medtronic, Europe on their closed loop insulin pump portfolio. KN has also received speaker's fee from Abbott for general lecturing on CGM use and from Medtronic for doing international insulin pump training courses for health-care providers. SS has served as adviser on hybrid closed-loop systems for Medtronic, Europe. Their research group at Steno Diabetes Center Copenhagen received funding for investigator-initiated studies from Dexcom in the form of rtCGMs for a type 2 study and from Medtronic to do a hybrid closed loop study in type 1 diabetes. Steno Diabetes Center Copenhagen is a public hospital and research institution under the Capital Region of Denmark, which is partly funded by a grant from the Novo Nordisk Foundation.",
year = "2021",
month = jun,
day = "12",
doi = "10.1016/S0140-6736(21)01211-3",
language = "English",
volume = "397",
pages = "2230--2232",
journal = "The Lancet",
issn = "0140-6736",
publisher = "The/Lancet Publishing Group",
number = "10291",
}